The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.
| Date | Insider | Role | Action | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Jun 17, 2026 | Bjorkquist Jeanette M | PFO and PAO | Sell(S) | 29 | $23.25 | $674 |
| Jun 4, 2026 | Johnson-Pratt Lisa | Director | Grant(A) | 8K | — | $0 |
| Jun 4, 2026 | Houghton Michael | Director | Grant(A) | 8K | — | $0 |
| Jun 4, 2026 | Mahony Susan | Director | Grant(A) | 8K | — | $0 |
| Jun 4, 2026 | Consylman Gina | Director | Grant(A) | 8K | — | $0 |
| Jun 4, 2026 | McHutchison John G | Director | Grant(A) | 8K | — | $0 |
| Jun 4, 2026 | Altig Anthony E | Director | Grant(A) | 8K | — | $0 |
| May 26, 2026 | Gilead Sciences, Inc. | 10% Owner | Grant(A) | 472K | $26.50 | $12.5M |
| Mar 30, 2026 | White Nicole S | Chief Manufacturing Officer | Sell(S) | 9 | $27.49 | $247 |
| Mar 30, 2026 | White Nicole S | Chief Manufacturing Officer | Sell(S) | 188 | $26.65 | $5K |
| Mar 30, 2026 | Bjorkquist Jeanette M | PFO and PAO | Sell(S) | 16 | $27.49 | $440 |
| Mar 30, 2026 | Bjorkquist Jeanette M | PFO and PAO | Sell(S) | 312 | $26.65 | $8K |
| Mar 29, 2026 | Okazaki Jason A | CEO and President, Director | Grant(A) | 51K | — | $0 |
| Mar 29, 2026 | Bjorkquist Jeanette M | PFO and PAO | Grant(A) | 4K | — | $0 |
| Mar 29, 2026 | Gaggar Anuj | Chief Medical Officer | Grant(A) | 14K | — | $0 |
| Mar 29, 2026 | White Nicole S | Chief Manufacturing Officer | Grant(A) | 14K | — | $0 |
| Mar 29, 2026 | Okazaki Jason A | CEO and President, Director | Grant(A) | 94K | — | $0 |
| Mar 29, 2026 | Delaney William E IV | Chief Scientific Officer | Grant(A) | 26K | — | $0 |
| Mar 29, 2026 | Gaggar Anuj | Chief Medical Officer | Grant(A) | 26K | — | $0 |
| Mar 29, 2026 | White Nicole S | Chief Manufacturing Officer | Grant(A) | 26K | — | $0 |
| Mar 29, 2026 | Bjorkquist Jeanette M | PFO and PAO | Grant(A) | 7K | — | $0 |
| Mar 29, 2026 | Delaney William E IV | Chief Scientific Officer | Grant(A) | 14K | — | $0 |
| Aug 8, 2025 | Gilead Sciences, Inc. | 10% Owner | Buy(P) | 2.3M | — | — |
| Aug 8, 2025 | Gilead Sciences, Inc. | 10% Owner | Buy(P) | 1.1M | — | — |
| Aug 8, 2025 | Gilead Sciences, Inc. | 10% Owner | Buy(P) | 1.1M | — | — |
| Jun 16, 2025 | Bjorkquist Jeanette M | PFO and PAO | Grant(A) | 300 | — | $0 |
| Jun 16, 2025 | Bjorkquist Jeanette M | PFO and PAO | Grant(A) | 600 | — | $0 |
| Jun 5, 2025 | Consylman Gina | Director | Grant(A) | 4K | — | $0 |
| Jun 5, 2025 | Altig Anthony E | Director | Grant(A) | 4K | — | $0 |
| Jun 5, 2025 | Ringo William R | Director | Grant(A) | 4K | — | $0 |
| Jun 5, 2025 | Johnson-Pratt Lisa | Director | Grant(A) | 4K | — | $0 |
| Jun 5, 2025 | McHutchison John G | Director | Grant(A) | 4K | — | $0 |
| Jun 5, 2025 | Mahony Susan | Director | Grant(A) | 4K | — | $0 |
| Jun 5, 2025 | Houghton Michael | Director | Grant(A) | 4K | — | $0 |
| Mar 31, 2025 | White Nicole S | Chief Manufacturing Officer | Sell(S) | 197 | $9.85 | $2K |
| Mar 31, 2025 | Okazaki Jason A | CEO and President, Director | Sell(S) | 355 | $9.85 | $3K |
| Mar 31, 2025 | Bjorkquist Jeanette M | Principal Accounting Officer | Sell(S) | 180 | $9.85 | $2K |
| Mar 31, 2025 | McHutchison John G | Director | Sell(S) | 757 | $9.85 | $7K |
| Mar 29, 2025 | Gaggar Anuj | Chief Medical Officer | Grant(A) | 24K | — | $0 |
| Mar 29, 2025 | White Nicole S | Chief Manufacturing Officer | Grant(A) | 20K | — | $0 |
| Mar 29, 2025 | Okazaki Jason A | CEO and President, Director | Grant(A) | 71K | — | $0 |
| Mar 29, 2025 | Bjorkquist Jeanette M | Principal Accounting Officer | Grant(A) | 2K | — | $0 |
| Mar 29, 2025 | Bjorkquist Jeanette M | Principal Accounting Officer | Grant(A) | 2K | — | $0 |
| Mar 29, 2025 | Delaney William E IV | Chief Scientific Officer | Grant(A) | 26K | — | $0 |
| Dec 30, 2024 | Houghton Michael | Director | Buy(P) | 3K | $15.61 | $50K |
| Dec 19, 2024 | Gilead Sciences, Inc. | 10% Owner | Buy(P) | 940K | $21.37 | $20.1M |
| Nov 25, 2024 | Schornstein Alexander | 10% Owner | Buy(P) | 3K | $15.00 | $45K |
| Nov 25, 2024 | Schornstein Alexander | 10% Owner | Buy(P) | 5K | $14.85 | $74K |
| Nov 22, 2024 | Schornstein Alexander | 10% Owner | Buy(P) | 17K | $14.87 | $253K |
| Nov 18, 2024 | White Nicole S | Chief Manufacturing Officer | Sell(S) | 40 | $16.29 | $652 |
| Oct 8, 2024 | Schornstein Alexander | 10% Owner | Buy(P) | 10K | $14.58 | $146K |
| Oct 3, 2024 | Okazaki Jason A | CEO and President, Director | Sell(S) | 197 | $14.81 | $3K |
| Oct 3, 2024 | White Nicole S | Chief Manufacturing Officer | Sell(S) | 157 | $14.81 | $2K |
| Aug 2, 2024 | Okazaki Jason A | CEO and President, Director | Sell(S) | 981 | $14.23 | $14K |
| Aug 2, 2024 | White Nicole S | Chief Manufacturing Officer | Sell(S) | 785 | $14.23 | $11K |
| Jul 5, 2024 | Schornstein Alexander | 10% Owner | Buy(P) | 4K | $12.52 | $56K |
| Jul 3, 2024 | Schornstein Alexander | 10% Owner | Buy(P) | 5K | $12.29 | $56K |
| Jun 17, 2024 | Gilead Sciences, Inc. | 10% Owner | Buy(P) | 180K | — | — |
| Jun 17, 2024 | Gilead Sciences, Inc. | 10% Owner | Buy(P) | 180K | — | — |
| May 29, 2024 | Ringo William R | Director | Grant(A) | 3K | — | $0 |
| May 29, 2024 | Altig Anthony E | Director | Grant(A) | 3K | — | $0 |
| May 29, 2024 | Consylman Gina | Director | Grant(A) | 3K | — | $0 |
| May 29, 2024 | Houghton Michael | Director | Grant(A) | 3K | — | $0 |
| May 29, 2024 | Mahony Susan | Director | Grant(A) | 3K | — | $0 |
| May 29, 2024 | McHutchison John G | Director | Grant(A) | 3K | — | $0 |
| May 29, 2024 | Johnson-Pratt Lisa | Director | Grant(A) | 3K | — | $0 |
| May 23, 2024 | White Nicole S | Chief Manufacturing Officer | Sell(S) | 172 | $14.93 | $3K |
| May 23, 2024 | Okazaki Jason A | CEO and President, Director | Sell(S) | 549 | $14.93 | $8K |
| May 23, 2024 | McHutchison John G | Director | Sell(S) | 2K | $14.93 | $32K |
| May 23, 2024 | Bjorkquist Jeanette M | Principal Accounting Officer | Sell(S) | 24 | $14.93 | $358 |
| Apr 30, 2024 | Okazaki Jason A | CEO and President, Director | Sell(S) | 2K | $12.71 | $20K |
| Apr 30, 2024 | White Nicole S | Chief Manufacturing Officer | Sell(S) | 1K | $12.71 | $16K |
| Apr 29, 2024 | Delaney William E IV | Chief Scientific Officer | Grant(A) | 3K | — | $0 |
| Apr 29, 2024 | Okazaki Jason A | CEO and President, Director | Grant(A) | 4K | — | $0 |
| Apr 29, 2024 | White Nicole S | Chief Manufacturing Officer | Grant(A) | 3K | — | $0 |
| Apr 1, 2024 | Okazaki Jason A | CEO and President, Director | Sell(S) | 354 | $13.07 | $5K |
| Apr 1, 2024 | White Nicole S | Chief Manufacturing Officer | Sell(S) | 197 | $13.07 | $3K |
| Apr 1, 2024 | Bjorkquist Jeanette M | Principal Accounting Officer | Sell(S) | 114 | $13.07 | $1K |
| Apr 1, 2024 | McHutchison John G | Director | Sell(S) | 1K | $13.07 | $16K |
| Mar 29, 2024 | Okazaki Jason A | CEO and President, Director | Grant(A) | 65K | — | $0 |
| Mar 29, 2024 | Delaney William E IV | Chief Scientific Officer | Grant(A) | 20K | — | $0 |
| Mar 29, 2024 | White Nicole S | Chief Manufacturing Officer | Grant(A) | 18K | — | $0 |
| Mar 29, 2024 | Bjorkquist Jeanette M | Principal Accounting Officer | Grant(A) | 850 | — | $0 |
| Mar 29, 2024 | Bjorkquist Jeanette M | Principal Accounting Officer | Grant(A) | 2K | — | $0 |
| Mar 27, 2024 | Okazaki Jason A | CEO and President, Director | Sell(S) | 392 | $12.87 | $5K |
| Jan 18, 2024 | Schornstein Alexander | 10% Owner | Buy(P) | 345K | $0.80 | $276K |
| Jan 17, 2024 | Schornstein Alexander | 10% Owner | Buy(P) | 300K | $0.78 | $234K |
| Nov 21, 2023 | Schornstein Alexander | 10% Owner | Buy(P) | 100K | $0.67 | $67K |
| Nov 20, 2023 | Schornstein Alexander | 10% Owner | Buy(P) | 300K | $0.72 | $216K |
| Nov 17, 2023 | White Nicole S | Chief Manufacturing Officer | Sell(S) | 477 | $0.69 | $329 |
| Nov 8, 2023 | Gaggar Anuj | Chief Medical Officer | Grant(A) | 500K | — | $0 |
| Oct 3, 2023 | Okazaki Jason A | CEO and President, Director | Sell(S) | 2K | $0.80 | $2K |
| Oct 3, 2023 | Delaney William E IV | Chief Scientific Officer | Sell(S) | 2K | $0.80 | $2K |
| Oct 3, 2023 | White Nicole S | Chief Manufacturing Officer | Sell(S) | 2K | $0.80 | $2K |
| Oct 2, 2023 | Okazaki Jason A | CEO and President, Director | Grant(A) | 13K | — | $0 |
| Oct 2, 2023 | Delaney William E IV | Chief Scientific Officer | Grant(A) | 10K | — | $0 |
| Oct 2, 2023 | White Nicole S | Chief Manufacturing Officer | Grant(A) | 10K | — | $0 |
| Aug 2, 2023 | Okazaki Jason A | CEO and President, Director | Sell(S) | 12K | $1.09 | $13K |
| Aug 2, 2023 | Delaney William E IV | Chief Scientific Officer | Sell(S) | 9K | $1.09 | $10K |
| Jul 24, 2023 | Bjorkquist Jeanette M | Principal Accounting Officer | Sell(S) | 844 | $1.07 | $903 |
Insider transactions sourced from SEC EDGAR Form 4 filings, normalized within minutes of acceptance. "Buy"/"Sell" mark open-market transactions (codes P/S), the tradeable signal. Awards, option exercises and tax-withholding are shown with their raw code. All data is public domain.
Coverage: Form 4 filings indexed 2021-01-04 → 2026-07-21. Earlier history is backfilling; this window widens as it deepens.
Programmatic access via the Arkolith API & MCP server (insider.transactions, insider.company).